Suppr超能文献

辣椒素诱导兔皮肤水肿机制的研究。

An investigation into the mechanism of capsaicin-induced oedema in rabbit skin.

作者信息

Newbold P, Brain S D

机构信息

Pharmacology Group, King's College, London.

出版信息

Br J Pharmacol. 1995 Feb;114(3):570-7. doi: 10.1111/j.1476-5381.1995.tb17177.x.

Abstract
  1. Oedema formation induced by intradermal capsaicin has been studied in rabbit skin. The effect of the anti-inflammatory steroid dexamethasone and also of a range of known inhibitors of oedema formation have been investigated in order to elucidate mechanisms involved in capsaicin-induced oedema formation. 2. Oedema formation, in response to intradermally-injected test agents, was measured by the local extravascular accumulation of intravenously injected 125I-labelled albumin. In separate experiments skin blood flow was assessed by the clearance of intradermally-injected 133xenon. 3. Oedema formation induced by intradermal histamine (3 nmol) and bradykinin (1 nmol), when in the presence of vasodilator doses of calcitonin gene-related peptide (CGRP) (3 pmol) or prostaglandin E1, (PGE1) (10 pmol), was significantly inhibited (P < 0.01) in rabbits pretreated with intravenous dexamethasone (3 mg kg-1, -4 h). In contrast dexamethasone had no effect on capsaicin (3 mumol)-induced oedema formation or, on capsaicin (30-100 nmol)-induced blood flow. 4. Oedema formation observed in response to intradermal capsaicin (3 mumol) was significantly inhibited (P < 0.01) when the selective capsaicin antagonist, ruthenium red (3 nmol) was co-injected. This suggests that the mechanism of capsaicin-induced oedema involves activation of sensory nerves. However, oedema was not inhibited when capsaicin was co-injected with the neurokinin NK1 receptor antagonist, RP67580 (10 nmol), the NK2 antagonist SR48960 (10 nmol) or the CGRP antagonist CGRP8-37 (300 pmol). 5. Oedema formation induced by capsaicin was not inhibited when co-injected with the histamine HI receptor antagonist, mepyramine (3 nmol), the PAF antagonist, WEB 2086 (100 nmol), the bradykinin B2 receptor antagonist, Hoel4O (1 nmol), or the cyclo-oxygenase inhibitor, indomethacin (10 nmol),suggesting that these mediators do not play a major role in the capsaicin-induced response.6. Histological analysis of capsaicin-treated skin sites revealed undamaged, intact microvessels and lack of haemorrhage. Further, co-injection of capsaicin with the hydrogen peroxide remover, catalase(2,200 u), had no effect on oedema formation. This suggests that capsaicin does not induce oedema formation secondary to free radical-induced damage.7. These results indicate that capsaicin-induced oedema in rabbit skin involves activation of sensory nerves. However, the oedema is not inhibited by pretreatment with the anti-inflammatory steroid,dexamethasone. Further the mechanisms which lead to the oedema formation observed after intradermal capsaicin remain unknown.
摘要
  1. 已在兔皮中研究了皮内注射辣椒素引起的水肿形成。为阐明辣椒素诱导水肿形成的相关机制,研究了抗炎类固醇地塞米松以及一系列已知的水肿形成抑制剂的作用。2. 通过静脉注射125I标记白蛋白的局部血管外积聚来测量皮内注射受试药物后引起的水肿形成。在单独的实验中,通过皮内注射133氙的清除率来评估皮肤血流量。3. 当存在血管舒张剂量的降钙素基因相关肽(CGRP)(3 pmol)或前列腺素E1(PGE1)(10 pmol)时,皮内注射组胺(3 nmol)和缓激肽(1 nmol)诱导的水肿形成在静脉注射地塞米松(3 mg kg-1,-4 h)预处理的兔中受到显著抑制(P < 0.01)。相比之下,地塞米松对辣椒素(3 μmol)诱导的水肿形成或辣椒素(30 - 100 nmol)诱导的血流没有影响。4. 当共同注射选择性辣椒素拮抗剂钌红(3 nmol)时,皮内注射辣椒素(3 μmol)引起的水肿形成受到显著抑制(P < 0.01)。这表明辣椒素诱导水肿的机制涉及感觉神经的激活。然而,当辣椒素与神经激肽NK1受体拮抗剂RP67580(10 nmol)、NK2拮抗剂SR48960(10 nmol)或CGRP拮抗剂CGRP8 - 37(300 pmol)共同注射时,水肿并未受到抑制。5. 当辣椒素与组胺H1受体拮抗剂美吡拉敏(3 nmol)、血小板活化因子拮抗剂WEB 2086(100 nmol)、缓激肽B2受体拮抗剂Hoel4O(1 nmol)或环氧化酶抑制剂吲哚美辛(10 nmol)共同注射时,辣椒素诱导的水肿形成未受到抑制,这表明这些介质在辣椒素诱导的反应中不发挥主要作用。6. 对辣椒素处理的皮肤部位进行组织学分析显示微血管未受损且完整,没有出血。此外,辣椒素与过氧化氢清除剂过氧化氢酶(2200 u)共同注射对水肿形成没有影响。这表明辣椒素不会继发于自由基诱导的损伤而引起水肿形成。7. 这些结果表明,兔皮中辣椒素诱导的水肿涉及感觉神经的激活。然而,抗炎类固醇地塞米松预处理并不能抑制水肿。此外,皮内注射辣椒素后导致水肿形成的机制仍然未知。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e816/1510027/1b4d2b57ab69/brjpharm00163-0019-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验